The role of sentinel node biopsy in male breast cancer

Maráz, Róbert; Boross, Gábor; Pap-Szekeres, József; Markó, László; Rajtár, Mária; Ambrózay, Éva

doi:10.1007/s12282-014-0535-1

Cited by 13 publications

(15 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our study showed men were less like to undergo sentinel node biopsy/sampling than women. There was no difference in rates of axillary dissection for invasive disease, as reflected by equivalent rates of >94% of males and females meeting the third KPI 21,22 . A greater proportion of males had stage II or III disease at diagnosis, and this may explain the higher likelihood of males undergoing level 1–3 axillary clearance, than females.…”

Section: Discussionmentioning

confidence: 94%

Male Breast Cancer in Australia

Lomma¹,

Chan

Chih

et al. 2020

Asia-Pac J Clncl Oncology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 94%

Male Breast Cancer in Australia

Lomma¹,

Chan

Chih

et al. 2020

Asia-Pac J Clncl Oncology

View full text Add to dashboard Cite

show abstract

“…There have been several series reporting ≥ 30 sentinel node biopsies for MBC, all from the USA which have been summarised in Table 2 [ 41 – 46 ]. The lowest identification rate (90%) occurred in the series in which not all cases received both isosulfan blue and technetium-99m [ 35 ].…”

Section: Sentinel Node Biopsymentioning

confidence: 99%

Surgical options for male breast cancer

Fentiman

2018

Breast Cancer Res Treat

View full text Add to dashboard Cite

BackgroundMale breast cancer (MBC) is a rare disease for which no randomised controlled trials (RCT) have been conducted to determine optimal surgical management. The available data have been reviewed to identify reasonable options and reveal areas in need of investigation.MethodsAll published series on the surgical management of MBC have been reviewed to determine approaches to treatment of the primary, the breast and the axilla together with the psychological sequelae of surgery.FindingsMastectomy is still the major surgical offer but a convincing case can be made for the use of neoadjuvant endocrine treatment in order to facilitate breast conserving surgery. Sentinel node biopsy has been successfully used for staging MBC although nomograms for prediction of nodal status are inadequately calibrated. There are psychological sequelae of mastectomy in males and as yet no evidence that the needs of those with MBC are being met.ConclusionsCollaborative studies are required so that men can participate in meaningful RCTs to provide an evidence-based rational foundation for the surgery of MBC.

show abstract

“…Successful SLN identification rates in the male breast cancer population have been reported to be 93 to 100 per cent in the literature, as shown in the Table 1. [6][7][8][9][10][11][12][13][14][15] Furthermore, a study by Rusby 14 et al evaluated the overall accuracy of SLN biopsy in male breast cancer and found that the identification rate was 96 per cent in 110 patients.…”

Section: Discussionmentioning

confidence: 99%

Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer

Şimşek

Belli

Aydoğan

et al. 2018

The American Surgeon™

View full text Add to dashboard Cite

Sentinel lymph node (SLN) biopsy is the main method in staging the axilla. There are insufficient data available regarding the accuracy of an SLN biopsy in male breast cancer. The aim of this study is to evaluate whether the combination of dye and radiotracer would improve the detection rate of SLNs versus dye alone in male breast cancer patients. From February 2009 to January 2012, our SLN biopsy database was retrospectively reviewed to identify male breast cancer cases. Of the 890 SLN procedures contained in the database, 10 male breast cancer patients were identified. Patient age, body mass index, SLN biopsy technique, SLN identification, number of SLN excised, and pathology reports were reviewed. Mean age was 57.2 (34–85) years with a mean tumor size was 2.2 (1.0–4.0) cm. SLN detection ratios were two in four with blue dye and six in six with the combination technique. Overall, SLNs were identified in 8 of the 10 patients. SLN biopsy is applicable in male breast cancer cases. The addition of a radiotracer to the dye in SLN biopsy increases the detection rate of sentinel nodes in male breast cancer patients.

show abstract

The role of sentinel node biopsy in male breast cancer

Cited by 13 publications

References 36 publications

Male Breast Cancer in Australia

Male Breast Cancer in Australia

Surgical options for male breast cancer

Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer

Contact Info

Product

Resources

About